Arcapta Neohaler is called Onbrez in Europe.
Arcapta Neohaler (Indacaterol)
Arcapta Neohaler is a medication primarily used to manage chronic obstructive pulmonary disease (COPD). It is a long-acting beta-2 adrenergic agonist (LABA) that helps open the airways in the lungs, making it easier to breathe.
It is not intended for the relief of acute symptoms but rather for daily maintenance to improve breathing and overall lung function in people with COPD.
Product Highlights
- Belongs to medicine class Long-Acting Beta-2 Agonist (LABA)
- Available in form of Inhalation powder.
- Administered via the Neohaler device, which delivers the medication directly to the lungs.
- It works by stimulating beta-2 adrenergic receptors in the bronchial muscles, leading to muscle relaxation and bronchodilation.
Key Ingredients
Key Benefits
- Improved breathing helps to keep the airways open, which improves airflow and reduces breathing difficulty.
- Provides bronchodilation for up to 24 hours, supporting better lung function throughout the day.
- Once-daily dosing makes it convenient and simplifies the management of COPD.
Direction For Use
- Preparation: Open the Neohaler device and place a capsule inside.
- Inhalation: Pierce the capsule using the device mechanism to release the powder.
- Breathe In: Inhale deeply through the mouthpiece to ensure the medication reaches your lungs.
- Close the Device: Remove the empty capsule and store the device properly.
- Frequency: Use it once daily as prescribed by your healthcare provider.
Safety Concern
- Common side effects include throat irritation, cough, headache, and nausea. Serious side effects may include chest pain, high blood pressure, and rapid heartbeat.
- Regular monitoring for potential side effects or complications is essential.
Avoid Arcapta Neohaler (Indacaterol) If
- You are allergic to indacaterol or any other component of the formulation.
- Arcapta Neohaler is not indicated for asthma and should not be used for this condition.
- People with severe heart conditions, such as severe coronary artery disease, should avoid this medication unless specifically advised by their healthcare provider.
- If you have a history of severe hypersensitivity reactions to similar medications.
